Cargando…

Correction to: Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report

Detalles Bibliográficos
Autores principales:	Sakurama, Keiki, Iguchi, Yuki, Haruki, Sara, Hata, Yusuke, Hiraga, Madoka, Yumoto, Shinya, Kai, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163797/ https://www.ncbi.nlm.nih.gov/pubmed/37147726 http://dx.doi.org/10.1186/s40780-023-00285-y

Ejemplares similares

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
por: Sakurama, Keiki, et al.
Publicado: (2023)

Rosuvastatin-Induced Rhabdomyolysis: A Case Report
por: Nikalji, Ravindra, et al.
Publicado: (2021)

Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin
por: Anklesaria, Zafia, et al.
Publicado: (2020)

Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
por: Wang, Wen, et al.
Publicado: (2022)

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
por: Koury, Mark J., et al.
Publicado: (2022)

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
por: Sarnak, Mark J, et al.
Publicado: (2023)

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2020)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2013)

Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin Use: A Case Report
por: Chitralli, Deepak, et al.
Publicado: (2020)

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
por: Haase, Volker H, et al.
Publicado: (2019)

Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, in Rodents
por: Kowalski, Heather, et al.
Publicado: (2023)

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
por: Calderon-Ospina, Carlos Alberto, et al.
Publicado: (2020)

Vadadustat, a HIF Prolyl Hydroxylase Inhibitor, Improves Immunomodulatory Properties of Human Mesenchymal Stromal Cells
por: Zielniok, Katarzyna, et al.
Publicado: (2020)

Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Xiong, Limei, et al.
Publicado: (2022)

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study
por: Nangaku, Masaomi, et al.
Publicado: (2021)

Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
por: McWilliam, Stephen J., et al.
Publicado: (2020)

Rhabdomyolysis Caused by Rhinovirus
por: Tan, Lay Ong, et al.
Publicado: (2016)

Correction: The Condition for Generous Trust
por: Obayashi, Shinya, et al.
Publicado: (2017)

Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy Adults
por: Paulson, Susan K., et al.
Publicado: (2022)

Correction: Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
Publicado: (2020)

A phase 3, open‐label, single‐arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis‐stimulating agents
por: Nangaku, Masaomi, et al.
Publicado: (2021)

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Rhabdomyolysis Caused by Gefitinib Overdose
por: Obayashi, Shohei, et al.
Publicado: (2021)

Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report
por: Mitaritonno, Michele, et al.
Publicado: (2021)

Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells
por: Takahashi, Haruko, et al.
Publicado: (2019)

Correction: Penehyclidine Hydrochloride Pretreatment Ameliorates Rhabdomyolysis-Induced AKI by Activating the Nrf2/HO-1 Pathway and Allevi-ating Endoplasmic Reticulum Stress in Rats
Publicado: (2016)

Correction: Factors affecting forest area change in Southeast Asia during 1980-2010
por: Imai, Nobuo, et al.
Publicado: (2018)

Correction: Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage
por: de Bragança, Ana C., et al.
Publicado: (2018)

Clinical characteristics of spinning-induced rhabdomyolysis and other causes of rhabdomyolysis: a comparative study
por: Shroff, Kashyap, et al.
Publicado: (2021)

Correction: Basic practices for gastrointestinal ultrasound
por: Nishida, Mutsumi, et al.
Publicado: (2023)

Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Author Correction: Cellular basis of omentum activation and expansion revealed by single-cell RNA sequencing using a parabiosis model
por: Ishigaki, Kazuhiko, et al.
Publicado: (2021)

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
por: Yamazaki, Daisuke, et al.
Publicado: (2013)

Correction to: Announcing changes to the publishing procedures of “Biophysics and Physicobiology” (BPPB)—the Biophysical Society of Japan’s English language biophysics journal
por: Nakamura, Haruki
Publicado: (2022)

Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
por: Rezigh, Alec B., et al.
Publicado: (2018)

Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
por: Patel, Chinmay, et al.
Publicado: (2019)

Rhabdomyolysis in an HIV cohort: epidemiology, causes and outcomes
por: Koubar, Sahar H., et al.
Publicado: (2017)

An undifferentiated cause of rhabdomyolysis: a case report
por: Patil, Pallavi, et al.
Publicado: (2023)

Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer
por: Shiozawa, Yusuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a55d5llqfbdscomje503rcmqcq